This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established Cannabis Capital Conference (CCC), at the Fontainebleau Miami Beach Hotel in Florida.
Together with superb keynote speakers and specialized leaders in psychedelics advisory, let’s take a glimpse at some of the leaders of well-established psychedelics companies on the speakers’ list of this exciting event.
Najla Guthrie, CEO Of Wellbeing Digital Sciences And A Scientific Visionary
Guthrie is CEO of one of the busiest companies among publicly-traded psychedelics firms. We’re also glad to say she’s part of Benzinga’s Psychedelic Advisory Council.
Wellbeing Digital Sciences (OTCMKTS: KONEF) is devoted to clinical research in the healthcare space with innovative psychedelic medicine and digital therapeutics with the help of its subsidiary and contract research organization (CRO) KGK Science.
The company's work includes studying the role of psychedelics in treating the complex FXS syndrome, a newly granted multiple drug manufacturing <a …